The study compared Semaglutide (Commercially: Ozempic for diabetes, Wegovy for weight-loss) against 7 other type 2 diabetes medications for its ability to prevent Alzheimer's disease in older type 2 diabetes patients, a critical group with 65% higher risk for developing…